The observation that both low and high expression levels of ERBB2 – also a RTK involved in many epithelial cancers [47] – are associated with the poor prognosis of primary breast cancers [48], illustrates that our finding does not stand completely on its own. The gene discussed is ERBB2; the disease is breast cancer.